Committee for Proprietary Medicinal Products
E23504
The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
Observed surface forms (1)
| Surface form | Occurrences |
|---|---|
| Committee for Medicinal Products for Human Use | 1 |
Statements (38)
| Predicate | Object |
|---|---|
| instanceOf |
regulatory committee
ⓘ
scientific committee ⓘ |
| appliesTo |
human medicinal products
ⓘ
medicinal products for human use authorised via the EU centralised procedure ⓘ |
| basedOn | EU pharmaceutical legislation ⓘ |
| collaboratesWith | national competent authorities of EU Member States ⓘ |
| country | European Union ⓘ |
| dissolvedIn | 2004 ⓘ |
| field |
medicinal products regulation
ⓘ
pharmacovigilance ⓘ public health ⓘ |
| hasAbbreviation | CPMP ⓘ |
| hasParentOrganization |
European Medicines Agency
ⓘ
surface form:
European Agency for the Evaluation of Medicinal Products
European Medicines Agency ⓘ |
| hasSuccessor | Committee for Medicinal Products for Human Use ⓘ |
| jurisdiction | European Union ⓘ |
| languageOfWork | English ⓘ |
| operatedBy | European Union ⓘ |
| operatedUnder |
European Union
ⓘ
surface form:
European Community
|
| partOf | European medicines regulatory system ⓘ |
| regulates | proprietary medicinal products ⓘ |
| regulatoryScope | centralised marketing authorisation procedure ⓘ |
| reorganizedInto | Committee for Medicinal Products for Human Use ⓘ |
| replacedBy |
Committee for Medicinal Products for Human Use
ⓘ
European Medicines Agency committee structure ⓘ |
| responsibleFor |
assessment of efficacy of medicines
ⓘ
assessment of quality of medicines ⓘ assessment of safety of medicines ⓘ evaluation of medicinal products ⓘ issuing scientific opinions on marketing authorisation applications ⓘ |
| sector |
healthcare regulation
ⓘ
pharmaceutical regulation ⓘ |
| supervisedBy | European Commission ⓘ |
| task |
adopt opinions on applications for marketing authorisation
ⓘ
evaluate benefit–risk balance of medicines ⓘ provide scientific advice to the European Commission ⓘ |
| workLocation |
London, England
ⓘ
surface form:
London
United Kingdom ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
Committee for Medicinal Products for Human Use